n.c_trader
Long

EGRX LOW RISK AND HIGHT REWARD

NASDAQ:EGRX   EAGLE PHARMACEUTICALS INC
35 1 2
EGRX             broke another key resistance zone , it is in a nice zone to a long entry.

And today:
Eagle Pharmaceuticals             , Inc. (Nasdaq:EGRX) today announced that the 505(b)(2) New Drug Application (NDA) for its novel ready-to-use bivalirudin product (“RTU bivalirudin”) has been accepted for filing by the U.S. Food and Drug Administration (FDA).

http://finance.yahoo.com/news/eagle-pharmaceuticals-rtu-bivalirudin-nda-110000493.html
timwest PRO
2 years ago
I wish I had found this stock a long time ago! That is some rally this year! $20 to $92 already. It looks like a lot of this news may already be in the stock? What's the risk here?
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out